Intellia Therapeutics NTLA
NASDAQ NTLA
$12.03 +0.61 (+5.34%)
At close: Sep 29, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) FCF Margin (2015 - 2026)

Updated

Intellia Therapeutics' FCF Margin came in at -1108.79% for Q2 2026, down 407.76 percentage points from -701.02% a year earlier and down 328.45 percentage points from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) FCF Margin (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Intellia Therapeutics reported FCF Margin of -585.97%, up 212.07 percentage points year-over-year; for FY2025, it was -584.98%, up 27.79 percentage points from FY2024.

  • FCF Margin carries a five-year change of -492.74 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -612.78% in FY2024 (+512.16 pp), -1124.94% in FY2023 (-459.48 pp), -665.46% in FY2022 (+53.95 pp) and -719.41% in FY2021 (-627.16 pp).
  • The Q2 2026 figure represents the lowest quarterly FCF Margin in data going back to Q1 2015.
  • Year-over-year, FCF Margin increased in four of the last seven quarters, with an average year-over-year change of +11.23 percentage points.
  • The fastest year-over-year change in FCF Margin over five years came in Q1 2024 (a gain of 472.00 percentage points), and the weakest in Q3 2021 (a drop of 833.91 percentage points).
  • Business Quant data shows NTLA's FCF Margin at -780.34% (Q1 2026), -301.56% (Q4 2025) and -558.18% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Intellia Therapeutics 1.60 Bn 1.60 Bn - -1,108.79%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,108.79%
Mar 31, 2026 -780.34%
Dec 31, 2025 -301.56%
Sep 30, 2025 -558.18%
Jun 30, 2025 -701.02%
Mar 31, 2025 -900.13%
Dec 31, 2024 -669.38%
Sep 30, 2024 -945.19%
Jun 30, 2024 -850.91%
Mar 31, 2024 -425.67%
Sep 30, 2023 -881.53%
Jun 30, 2023 -696.07%
Mar 31, 2023 -897.67%
Dec 31, 2022 -690.94%
Sep 30, 2022 -623.87%
Jun 30, 2022 -634.86%
Mar 31, 2022 -721.92%
Dec 31, 2021 -447.48%
Sep 30, 2021 -965.57%
Jun 30, 2021 -853.73%
API Access

Intellia Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NTLA&period=max&api_key=YOUR_API_KEY